We are live on
!
Find out more
VEA
Virtus ETF Advisers Portfolio holdings
AUM
$215M
1-Year Est. Return
53.68%
This Fund
S&P 500
This Quarter
Est. Return
+11.92%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$191M
AUM Growth
-$59.3M
(-24%)
Cap. Flow
-$76.2M
Cap. Flow
% of AUM
-39.78%
Top 10 Holdings %
Top 10 Hldgs %
5.8%
Holding
489
New
53
Increased
164
Reduced
226
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
D.R. Horton
DHI
|
+$888K |
| 2 |
Lennar Class A
LEN
|
+$880K |
| 3 |
Microchip Technology
MCHP
|
+$860K |
| 4 |
Ametek
AME
|
+$859K |
| 5 |
Home Depot
HD
|
+$853K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Steel Dynamics
STLD
|
+$1.62M |
| 2 |
Cheniere Energy
CQP
|
+$1.53M |
| 3 |
STOR
STORE Capital Corporation
STOR
|
+$1.44M |
| 4 |
NOA
North American Construction
NOA
|
+$1.43M |
| 5 |
STR
Sitio Royalties
STR
|
+$1.41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.88% |
| 2 | Financials | 12.6% |
| 3 | Technology | 10.15% |
| 4 | Materials | 9.55% |
| 5 | Real Estate | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
SL Green Realty
SLG
$3.77B
| $336K | 0.18% |
9,953
-22,501
| -69% | -$856K |
|
227
Roivant Sciences
ROIV
$24.3B
| $335K | 0.17% |
41,905
-21,151
| -34% | -$118K |
|
228
Horizon Technology Finance
HRZN
$295M
| $335K | 0.17% |
28,847
-8,382
| -23% | -$100K |
|
|
PHD
229
DELISTED
Pioneer Floating Rate Fund
PHD
| $333K | 0.17% |
37,951
-4,257
| -10% | -$37.1K |
|
230
Prospect Capital
PSEC
$1.12B
| $331K | 0.17% |
47,348
-10,592
| -18% | -$76.2K |
|
231
Sixth Street Specialty
TSLX
$1.68B
| $329K | 0.17% |
18,492
-4,244
| -19% | -$76.1K |
|
232
Petrobras
PBR
$116B
| $329K | 0.17% |
30,890
-102,769
| -77% | -$1.24M |
|
233
NRG Energy
NRG
$26.9B
| $329K | 0.17% |
10,330
-31,627
| -75% | -$1.25M |
|
|
PRVB
234
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $329K | 0.17% |
+31,095
| New | +$251K |
|
235
Mirum Pharmaceuticals
MIRM
$6.84B
| $327K | 0.17% |
16,790
+4,472
| +36% | +$88.4K |
|
236
Alico
ALCO
$284M
| $323K | 0.17% |
13,544
-26,382
| -66% | -$763K |
|
|
PNNT
237
Pennant Park Investment Corp
PNNT
$221M
| $323K | 0.17% |
56,113
-10,866
| -16% | -$63.7K |
|
|
NSL
238
DELISTED
NUVEEN SENIOR INCM FD
NSL
| $322K | 0.17% |
70,201
-8,963
| -11% | -$42.2K |
|
239
Stellus Capital Investment Corp
SCM
$211M
| $320K | 0.17% |
24,149
-8,044
| -25% | -$106K |
|
240
ADMA Biologics
ADMA
$2.04B
| $320K | 0.17% |
+82,439
| New | +$254K |
|
241
Ares Capital
ARCC
$13.7B
| $319K | 0.17% |
17,264
-3,314
| -16% | -$62.2K |
|
|
ONC
242
BeOne Medicines Ltd
ONC
$34.3B
| $318K | 0.17% |
1,446
-335
| -19% | -$61.4K |
|
243
Enanta Pharmaceuticals
ENTA
$367M
| $316K | 0.17% |
6,800
+917
| +16% | +$41.8K |
|
244
Ligand Pharmaceuticals
LGND
$5.94B
| $315K | 0.16% |
4,721
-327
| -6% | -$21.3K |
|
|
JRO
245
DELISTED
Nuveen Floating Rate Income Opportunty Fund
JRO
| $313K | 0.16% |
40,057
-4,634
| -10% | -$37.3K |
|
|
DCPH
246
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $312K | 0.16% |
19,052
-2,692
| -12% | -$43.8K |
|
247
BioCryst Pharmaceuticals
BCRX
$2.48B
| $311K | 0.16% |
27,086
+2,166
| +9% | +$27K |
|
248
Nuveen Floating Rate Income Fund
JFR
$1.24B
| $310K | 0.16% |
39,200
-4,478
| -10% | -$36.6K |
|
249
Sarepta Therapeutics
SRPT
$1.63B
| $310K | 0.16% |
2,395
-1,258
| -34% | -$146K |
|
|
CTIC
250
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $310K | 0.16% |
51,542
+8,172
| +19% | +$44.6K |
|
Similar funds
NCM
SSA
LIWM
VFG
IAM
1M
GC
RC
Virtus ETF Advisers's Q4 2022 Portfolio in Review
As of Q4 2022, Virtus ETF Advisers held 489 positions worth $191M, down 24% from $251M the previous quarter. Its ten largest holdings account for 5.8% of the portfolio.
Virtus ETF Advisers withdrew a net $76.2M in Q4 2022, closing 46 positions and reducing 226 holdings. Its most notable exit was iShares JPMorgan USD Emerging Markets Bond ETF, an estimated $877K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 19% a quarter earlier, followed by Financials and Technology.
Against the trend, Virtus ETF Advisers opened a new position in D.R. Horton worth $987K.
- Virtus ETF Advisers's largest Q4 2022 buy was D.R. Horton: 11,078 shares worth $987K.
- Virtus ETF Advisers added most to Qualcomm in Q4 2022, an estimated $271K increase.
- Virtus ETF Advisers's biggest Q4 2022 reduction was Steel Dynamics, cutting an estimated $1.62M.
- Virtus ETF Advisers fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q4 2022, selling an estimated $877K.
- Virtus ETF Advisers's ten largest holdings make up 5.8% of its $191M portfolio in Q4 2022.
- Virtus ETF Advisers opened 53 new positions and closed 46 in Q4 2022.
- Virtus ETF Advisers's portfolio value fell 24% quarter-over-quarter to $191M.
Based on Virtus ETF Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.